Cancer cure? CAR T-cell therapy has two people in remission 10 years later

Summary

This article by Jessica Norris, writing for Medical News Today, makes the following points:

• Researchers found that a form of Chimeric antigen receptor (CAR) T-cell cancer treatment was effective in treating leukaemia, keeping two people’s cancer in remission 10 years later.
• CAR T-cell therapy is a type of immunotherapy treatment that enhances the body’s immune response to fight off cancerous cells.
• The study found that two patients with leukaemia were cancer-free nearly a decade after receiving CAR T-cell therapy.
• More research is necessary to determine how effective CAR T-cell therapy is in treating different types of cancer.

References

Recent Runway Posts related to this topic:

• Could Australia become the first country to eliminate cervical cancer? Experts say it's possible | The Runway (airforce.gov.au)
• Thousands of tiny anchors keep our cells in place (and now we know how) | The Runway (airforce.gov.au)

References from the Web:

• FEB 2022 Two patients declared 'cured' of leukaemia, a decade after innovative treatment that has transformed blood cancer care—USA Today
• FEB 2022T-cell immunotherapy tied to 10-year remission in two leukaemia patients, study finds—CNN  

Source Information:

• Article Source: Medical and health information (medicalnewstoday.com)
• Media Check: Medical News Today - Media Bias/Fact Check (mediabiasfactcheck.com)
• LEARNING OUTCOMES—RUNWAY | The Runway (airforce.gov.au)